Skip to main content

Swiss Re: ASIA-PACIFIC MORTALITY PROTECTION GAP – THE TIME FOR ACTION IS NOW


Asia-Pacific Mortality Protection Gap – the time for action is now


A new study published by Swiss Re in Asia-Pacific quantifies the total mortality protection gap across 12 insurance markets to be USD 41 trillion

Paul Turner, Swiss Re’s Head of Client Management, Reinsurance Client Markets, Division Globals, and David Alexander, Swiss Re’s Head of Business Development Asia, joint authors of the report, highlight some key findings.

Despite numerous industry studies and awareness campaigns, there is still a significant mortality protection gap in all Asia-Pacific markets. 

Swiss Re’s recently published study, Mortality Protection Gap: Asia-Pacific 2011the first to feature multiple Asia-Pacific marketsfinds that the aggregate mortality protection gap across 12 Asia-Pacific markets expanded significantly from USD 16 trillion in 2000 to USD 41 trillion in 2010 (see figure 1).  

This equates to a massive opportunity for the industry – the mortality protection gap is worth approximately USD 124.2 billion in potential premiums to the industry!

The results of the study pose a number of questions on both the demand and supply sides of life insurance.

Demand side:

  • Does the traditional reliance on support from the extended family in Asia significantly reduce demand for insurance solutions and will this continue to be the case in the future?
  • Will customers in Asia see the value of life insurance without an investment element and buy the required levels of protection?



Supply side:

  •  Is the industry doing enough to articulate the value and cost of life insurance products? Clear messages such as “for less than a cup of coffee per day, you can protect your family” can be very powerful motivators to act.
  •  Do our distribution channels offer the broadest access points to our products?
  • Do we need to “reinvent” medical underwriting to remove sales barriers without compromising prudent risk management standards?
Forty percent (40%) of the respondents to Swiss Re’s "Survey of Risk Appetite and Insurance: Asia-Pacific 2011”1) said their families would or might struggle financially in case of an adverse event such as early death. 

The survey identifies the major barriers to purchasing insurance
1) cost and 
2) lack of available funds.

Despite the perception that life insurance is expensive, over half of the survey respondents are willing to pay at or even above the market price for a life insurance product. 

This gap in customer perception is a clear opportunity for the life insurance industry.

In addition to more customer education with regard to the benefits and costs of life insurance products, life insurers are adopting a number of different strategies including:
  • Diversifying distribution channels and aligning channels with customer segments and products: for example, pure protection products such as term life insurance sold via direct marketing channels such as mail, telephone and the Internet.
  • Proactively topping up the coverage of existing customers as they go through life and protection need changes and increases. Direct consumer marketing channels will often complement agency forces in this space.
  • Introducing data analytics to target customers who match certain risk profiles and to significantly reduce the medical underwriting burden.
In general, it is clear that more needs to be done in terms of supporting the general public in life insurance matters. 

The Australian insurance industry has led the way in the region in recent years, working collectively to promote greater awareness of the benefits of life insurance protection to the general public. 

This work, together with an increase in alternative distribution channels and sales of protection through superannuation funds, has helped reduce the protection gap in Australia.

The continuing growth of Asia-Pacific economies will drive the need for life insurance protection. 

Thus, there has never been a better time for insurers to understand our customers’ protection needs, address challenges and work together to capture the opportunities ahead of us.


Between April and May 2011, Swiss Re commissioned a large-scale survey covering 13,800 consumers aged 20 to 40 in Asia-Pacific; the survey aimed to gauge consumer attitudes towards four risk aspects and look into the insurance needs and buying behaviours of target consumers across the region.

Please contact your Swiss Re client manager for further details on our research and solutions relating to the protection gap.

Published September 2011
Source: http://www.swissre.com/reinsurance/insurers/life_health/Mortality_Protection_Gap.html?mobile=iphone



Comments

Popular posts from this blog

PRIVATE RETIREMENT SCHEME (PRS)

PRIVATE RETIREMENT SCHEME (PRS) Development of the PRS Industry With increasing life expectancy and rising living standards , many Malaysians find that their savings are inadequate to meet their retirement needs.  PRS form an integral feature of the private pension industry with the objective of improving living standards for Malaysians at retirement through additional savings of funds . As long-term investment vehicles, PRS are designed to help enhance adequacy and expand coverage of retirement benefits to all segments of the population. It complements Malaysia’s mandatory retirement savings schemes . Contributions to the PRS are voluntary .  Individuals (retail investors, self-employed and employees) or  employers can participate as PRS contributors.  Offering private pension benefits could be a tool for employers to attract and retain skilled talent. The PRS information set out in this publication includes a description of the framework, the key feature

MedicineNet: Diabetes Mellitus

MedicineNet: Diabetes Mellitus Diabetes facts ·          Diabetes is a chronic condition associated with abnormally high levels of sugar (glucose) in the blood. Insulin produced by the pancreas lowers blood glucose . Absence or insufficient production of insulin causes diabetes. The two types of diabetes are referred to as type 1 and type 2 . Former names for these conditions were insulin-dependent and non-insulin-dependent diabetes , or juvenile onset and adult onset diabetes . Symptoms of diabetes include increased urine output, thirst, hunger, and fatigue . Diabetes is diagnosed by blood sugar (glucose) testing . The major complications of diabetes are both acute and chronic. Acute complications : dangerously elevated blood sugar (hyperglycemia), abnormally low blood sugar (hypoglycemia) due to diabetes medications may occur Chronic complications : disease of the blood vessels (both small and large) which can damage the feet, eyes, kidneys, nerves,

MedicineNet : Lung Cancer

Lung Cancer http://www.medicinenet.com What is lung cancer? Cancer of the lung, like all cancers, results from an abnormality in the body's basic unit of life, the cell. Normally, the body maintains a system of checks and balances on cell growth so that cells divide to produce new cells only when new cells are needed. Disruption of this system of checks and balances on cell growth results in an uncontrolled division and proliferation of cells that eventually forms a mass known as a tumor. Tumors can be benign or malignant ; when we speak of "cancer," we are referring to those tumors that are malignant. Benign tumors usually can be removed and do not spread to other parts of the body. Malignant tumors , on the other hand, grow aggressively and invade other tissues of the body, allowing entry of tumor cells into the bloodstream or lymphatic system and then to other sites in the body. This process of spread is termed metastasis ; the areas of tum